Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 

This article is part of the supplement: 35te Tagung der Pathologen am Oberrhein/35th Meeting of Pathologists of the Upper Rhine Region (PATOR) .

Open AccessOral presentation

Life-threatening endocrinologic paraneoplasia in an 83-year-old patient with solitary fibrous tumor of the pleura: a case report

U Oehler

Institut für Pathologie, Hegau-Bodensee-Hochrheinkliniken, 78207 Singen, Germany

corresponding author email

from 35te Tagung der Pathologen am Oberrhein/35th Meeting of Pathologists of the Upper Rhine Region (PATOR)
The Institute of Pathology, University Hospital Freiburg, Germany. 1 July 2006

Diagnostic Pathology 2007, 2(Suppl 1):S13doi:10.1186/1746-1596-2-S1-S13

Published: 14 March 2007

© 2007 Oehler; licensee BioMed Central Ltd.

Case report

An 83-year-old male patient with progressive alterations in behavior and aggressiveness was suspected of psychiatric disease. Loss of conscience led to hospital admission. The blood glucose was reduced to 11 g/100 ml and insulinoma could be clinically excluded.

5 months before, the patient had refused to be operated on for a large (20 cm) pleural tumor. Punch biopsy had revealed a solitary fibrous tumor. The hypoglycemia was regarded to be paraneoplastic due to IGF-II production, which is known to occur in about 5% of patients with this disease. As the condition got rapidly worse (the patient had to be wakened every hour at night due to hypoglycaemia), the patient finally agreed to surgery. During the operation, the blood glucose level rose to 200 mg/100 ml, and the patient is well since. The clinically problematic hypoglycemia, in this case, appears to be a matter of size of the tumor which had clinically grown during the past 5 months, whereas the lesion had been incidentally detected on a chest x-ray 37 years before in 1969, when the patient had also refused surgery.

The pathologist should be aware of this although rare complications in an otherwise non malignant tumor and inform the clinician.

Have something to say? Post a comment on this article!


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.